CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $203.22M, lower than 95% of all stocks globally
- PositionP/E ratio is 10.37×, lower than 95% of its Health Information Services peers (median 44.38×)
- Interpretations8 currently firing — 8
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.39%
Annual Rate
JPY 38.00Paid annual
Payout Ratio
14.4%Sustainable
Next Ex-Dividend
Mar 30, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
32.20BJPY203.22M · vs all stocks (USD)
Trailing P/E
10.37xvs Health Information Services peers
Revenue (TTM)
13.06BJPY82.43M · vs all stocks (USD)
Profit Margin
24.42%vs Health Information Services peers
52-Week Change
-29.52%vs all stocks
Market Capitalization
32.20BJPY203.22M · vs all stocks (USD)
Enterprise Value
28.69BJPY181.06M · vs all stocks (USD)
Trailing P/E
10.37xvs Health Information Services peers
Forward P/E
12.01xvs Health Information Services peers
PEG Ratio
0.4231xPrice to Sales (TTM)
2.38xvs Health Information Services peers
Price to Book (MRQ)
2.76xvs Health Information Services peers
Enterprise to Revenue
2.20xvs Health Information Services peers
Enterprise to EBITDA
6.54xvs Health Information Services peers
Profit Margin
24.42%vs Health Information Services peers
Operating Margin
21.52%vs Health Information Services peers
Return on Assets (TTM)
11.78%vs Health Information Services peers
Return on Equity (TTM)
32.12%vs Health Information Services peers
Revenue (TTM)
13.06BJPY82.43M · vs all stocks (USD)
Revenue per Share (TTM)
1.16KJPYUpdated Aug 20, 2026Quarterly Revenue Growth
25.00%vs Health Information Services peers
Gross Profit (TTM)
7.38BJPY46.58M · vs all stocks (USD)
EBITDA (TTM)
4.18BJPY26.41M · vs all stocks (USD)
Net Income (TTM)
3.19BJPY20.12M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
61.40%vs Health Information Services peers
Operating Cash Flow (TTM)
2.95BJPY18.60M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.95BJPY18.64M · vs all stocks (USD)
Trailing Annual Dividend Rate
38.00JPYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.39%vs all stocks
Payout Ratio
14.44%vs Health Information Services peers
Minority Interest (Equity)
111.58MJPYFY2026 · Mar 31, 2026Revenue
12.33BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
5.36BJPYFY2026 · Mar 31, 2026Gross Profit
6.97BJPYFY2026 · Mar 31, 2026Operating Income
2.68BJPY16.93M · vs all stocks (USD)
Pre-tax Income
2.62BJPYFY2026 · Mar 31, 2026Income Tax Expense
-377.38MJPYFY2026 · Mar 31, 2026Net Income
3.00BJPYFY2026 · Mar 31, 2026EBIT
2.64BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
4.18BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
6.29MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
13.43MJPYFY2026 · Mar 31, 2026Minority Interests (P&L)
-47.02MJPYFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
1.95BJPYFY2026 · Mar 31, 2026Free Cash Flow
1.93BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
5.24BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
2.62BJPYFY2026 · Mar 31, 2026Other Non-cash Items
2.98MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-492.42MJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-185.28MJPYFY2026 · Mar 31, 2026Capital Expenditures
-16.51MJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
-1.57BJPYFY2026 · Mar 31, 2026Net Acquisitions
1.34MJPYFY2026 · Mar 31, 2026Purchase of Investments
-257.12MJPYFY2026 · Mar 31, 2026Sale of Investments
51.15MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-221.13MJPYFY2026 · Mar 31, 2026Long-term Debt Issuance
1.00BJPYFY2026 · Mar 31, 2026Long-term Debt Payments
-1.09BJPYFY2026 · Mar 31, 2026Net Short-term Debt Issuance
2.00BJPYFY2026 · Mar 31, 2026Common Stock Repurchase
-1.01BJPYFY2026 · Mar 31, 2026Common Dividends Paid
-264.76MJPYFY2026 · Mar 31, 2026Other Financing Charges
-1.00KJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
1.23BJPYFY2026 · Mar 31, 2026Shares Outstanding
11.46MSharesUpdated Aug 20, 2026Float Shares
1.46MSharesUpdated Aug 20, 2026% Held by Insiders
71.45%vs all stocks
% Held by Institutions
7.67%vs all stocks
Total Cash (MRQ)
4.51BJPY28.46M · vs all stocks (USD)
Total Cash per Share (MRQ)
395.89JPYUpdated Aug 20, 2026Total Debt (MRQ)
2.88BJPY18.18M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2514xvs Health Information Services peers
Current Ratio (MRQ)
1.78xvs Health Information Services peers
Book Value per Share (MRQ)
991.11JPYUpdated Aug 20, 2026Total Assets
17.82BJPY112.45M · vs all stocks (USD)
Total Current Assets
10.09BJPYFY2026 · Mar 31, 2026Total Liabilities
6.35BJPYFY2026 · Mar 31, 2026Total Non-current Assets
7.73BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
1.15BJPYFY2026 · Mar 31, 2026Total Current Liabilities
5.20BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
5.20BJPYFY2026 · Mar 31, 2026Accounts Receivable
4.06BJPYFY2026 · Mar 31, 2026Inventory
343.15MJPYFY2026 · Mar 31, 2026Accounts Payable
201.41MJPYFY2026 · Mar 31, 2026Short-term Debt
2.00BJPYFY2026 · Mar 31, 2026Other Current Liabilities
722.25MJPYFY2026 · Mar 31, 2026Long-term Debt
821.17MJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
327.57MJPYFY2026 · Mar 31, 2026Common Stock (Book)
68.86MJPYFY2026 · Mar 31, 2026Retained Earnings
6.50BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
11.46BJPY72.36M · vs all stocks (USD)
Treasury Stock
0.00JPYFY2026 · Mar 31, 202652-Week Low
2.06KJPYUpdated Aug 20, 202652-Week High
4.68KJPYUpdated Aug 20, 202652-Week Change
-29.52%vs all stocks
50-Day MA
2.45KJPYUpdated Aug 20, 2026200-Day MA
2.65KJPYUpdated Aug 20, 2026Avg 10-Day Volume
90.07KSharesUpdated Aug 20, 2026Avg 30-Day Volume
72.72KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
263.34JPYUpdated Aug 20, 20268 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Working Capital Pattern
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Multi-Year FCF With Growth And Margin
Three years of positive free cash flow and rising revenue, four of rising equity, and much of its sales turns into cash.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 10.37×, lower than 95% of its Health Information Services peers (median 44.38×)Notable
P/E ratio: 10.37Industry median: 44.38Industry P5: 13.98Peers compared: 33.00
Financial Health
Altman Z-Score 5.06: safe zoneNotable
Altman Z-Score: 5.06
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $203.22M, lower than 95% of all stocks globallySignificant
Market cap (USD): 203,224,125.663Global P5: 269,387,740.27
Levered free cash flow is $18.64M, above the global median of $16.24MNotable
Levered free cash flow (USD): 18,636,532.719Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Beeks Financial Cloud Group PLC
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Spok Holdings Inc.
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Exodus Movement, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Fonix PLC
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Danal Co. Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Hennge K.K.
Tier 1FlowRecurring-Revenue Lock-InRuleProduction
8x8 Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
MTI Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Soracom Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
GMO Financial Gate Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Digital Information Technologies Corporation
7 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthWorking Capital PatternMulti-Year FCF With Growth And Margin
Harmony Biosciences Holdings, Inc.
7 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthWorking Capital PatternMulti-Year FCF With Growth And Margin
Future Corporation
7 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesFCF Ratios ElevatedROE, ROA, And Operating ROA ElevatedRevenue Growing With Receivables GrowingMulti-Year Revenue, Profit, And Income GrowthWorking Capital PatternMulti-Year FCF With Growth And Margin